EID Parry
EID Parry Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
0 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
Nutraceuticals (Nutra) segment expected to achieve highest ever revenue and healthy EBITDA in the current year, driven by Valensa’s growth and new product launches, particularly in dermal, hair, and skin health. - Consumer Product Group (CPG) division: Revenues intentionally reduced to focus on margin-accretive products; expected to achieve quarterly breakeven in 4-5 quarters. - CPG growth drivers: Value mix shift towards value-added products, introduction of new products like jaggery and brown sugar, distribution expansion especially in general trade, and strengthening brand equity. - Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. Core sugar and biofuels business aims for consistent EBITDA generation with efficiency and cost improvements, especially in underperforming states (Page 12).
From EID Parry's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Nutraceuticals (Nutra) segment expected to achieve highest ever revenue and healthy EBITDA in the current year, driven by Valensa’s growth and new product launches, particularly in dermal, hair, and skin health.
- Consumer Product Group (CPG) division: Revenues intentionally reduced to focus on margin-accretive products; expected to achieve quarterly breakeven in 4-5 quarters.
- CPG growth drivers: Value mix shift towards value-added products, introduction of new products like jaggery and brown sugar, distribution expansion especially in general trade, and strengthening brand equity.
- Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. 100 crores turnover with substantially better margins than white sugar.
- Sugar volumes expected to be flat or decrease slightly (~5%) in Tamil Nadu and Andhra Pradesh, potentially offset by stronger crush in Karnataka if weather conditions are favorable.
- Overall, calibrated growth with margin focus and operational restructuring prioritized over aggressive volume expansion.
Profitability & Margins
See what EID Parry said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No imminent significant capex plans were indicated during the call.
- The company is commissioning a new jaggery plant in Karnataka within 6 months, which will more than double current jaggery capacity.
- The new jaggery plant is expected to contribute about Rs. 100 crores in turnover.
- The company is focusing on growing the consumer product group (CPG) business, including value-added products like jaggery and brown sugar.
- Exploring new product categories both organically and inorganically.
- Working on monetization of non-core assets (mainly land parcels) to reduce debt, expected to happen in FY '27.
- No major restructuring in Tamil Nadu sugar business currently planned but efficiency improvements are ongoing.
- Overall focus on improving working capital, cost reduction, and strengthening the balance sheet rather than heavy capital investment.
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what EID Parry said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
EID Parry — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹7.9K Cr, net loss ₹287 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What EID Parry (India) Ltd's management said in earlier quarters
Others in Food Products this season
- Foods & Inns Ltd (Q1 FY27)
. Key concall takeaways from Foods & Inns Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Avanti Feeds Ltd (Q1 FY27)
Investment of around INR 175 crores planned in pet food, with INR 25 crores spent on land so far. Key concall takeaways from Avanti Feeds Ltd's Q1 FY27…
- Ganesh Consumer Products Ltd (Q1 FY27)
Profit after tax (PAT) for Q1 FY27 stood at INR125 million, up 31.4% YoY with a PAT margin expansion of 191 bps YoY. Key concall takeaways from Ganesh Consumer…
- Apex Frozen Foods Ltd (Q1 FY27)
Profitability improved significantly in Q1 FY27 with a 79% YoY EBITDA increase and 138% PAT growth, driven by higher realizations, stable farm gate prices, and…
Frequently Asked Questions
What were EID Parry Q1 FY27 results?
Nutraceuticals (Nutra) segment expected to achieve highest ever revenue and healthy EBITDA in the current year, driven by Valensa’s growth and new product launches, particularly in dermal, hair, and skin health. - Consumer Product Group (CPG) division: Revenues intentionally reduced to focus on margin-accretive products; expected to achieve quarterly breakeven in 4-5 quarters. - CPG growth drivers: Value mix shift towards value-added products, introduction of new products like jaggery and brown sugar, distribution expansion especially in general trade, and strengthening brand equity. - Jaggery capacity doubling with new plant commissioning in Karnataka, targeting approx Rs. Core sugar and biofuels business aims for consistent EBITDA generation with efficiency and cost improvements, especially in underperforming states (Page 12).
What is EID Parry share price analysis?
EID Parry currently shows a neutral. The stock trades at a P/E of 17.5 with a market cap of ₹14,188 Cr. Investors should review the full earnings analysis for detailed insights.
Is EID Parry planning capital expenditure?
No imminent significant capex plans were indicated during the call. - The company is commissioning a new jaggery plant in Karnataka within 6 months, which will more than double current jaggery capacity. - The new jaggery plant is expected to contribute about Rs.
Keep EID Parry on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.